Bright Minds Biosciences Inc. (DRUG:NASDAQ) jumped higher at $1.08, a gain of 22.2%. On Tue, Jul 26, 2022, DRUG:NASDAQ touched a New 2-Week High of $1.08. The stock got featured on our News Catalysts scanner on Mon, Jun 27, 2022 at 07:18 AM in the 'INVESTOR UPDATE' category. From Tue, Jul 12, 2022, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Wed, Jul 20, 2022 at $1.25 with a volume of 1M+.
About Bright Minds Biosciences Inc. (DRUG:NASDAQ)
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
Top 10 Gainers:
- Ayala Pharmaceuticals, Inc. (AYLA:NASDAQ), 94.25%
- Pagaya Technologies Ltd. (PGY:NASDAQ), 73.11%
- Freight Technologies Inc Com (FRGT:NASDAQ), 67.57%
- Comera Life Sciences Holdings Inc. (CMRA:NASDAQ), 60.82%
- InflaRx N.V. (IFRX:NASDAQ), 38.13%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 30.08%
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 28.42%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 24.61%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 22.16%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 19.86%